Research Group of Pharmaceutics - School of Pharmacy, Bandung Institute of Technology, Ganesa 10, Bandung, 40132, Indonesia; Research Center for Nanosciences and Nanotechnology, Bandung Institute of Technology, Ganesa 10, Bandung, 40132, Indonesia.
Dexa Laboratories of Biomolecular Sciences, Dexa Medica, Industri Selatan V PP-7, Jababeka II Industrial Estate, Cikarang, 17550, Indonesia.
Biochem Biophys Res Commun. 2019 Jul 12;515(1):99-103. doi: 10.1016/j.bbrc.2019.05.107. Epub 2019 May 23.
A recently discovered lectin-like protein from mushroom tyrosinase designated as orf239342 inhibits proliferation of the MCF-7 breast cancer cells. This characteristic is likely derived from its ability to recognize sugar entity on the cell surface. Thereby, the binding specificity of orf239342 to sugars was studied. Orf239342 was found to bind specifically to mannose upon analysis with the surface plasmon resonance technique. Finally, our in vitro study showed that mannose impeded orf239342 ability to inhibit proliferation of the MCF-7 breast cancer cells, providing further evidence for the mannose binding onto the protein. Our finding is a breakthrough to characterise orf239342 i.e. to define its functioning in the mushroom, association to the tyrosinase, or even possible application in breast cancer therapy. In addition, the finding allows the more appropriate designation of the protein as Agaricus bisporus mannose binding-protein (AbMb).
一种从蘑菇酪氨酸酶中发现的凝集素样蛋白,被命名为 orf239342,可抑制 MCF-7 乳腺癌细胞的增殖。这一特性可能源于其识别细胞表面糖基的能力。因此,研究了 orf239342 与糖的结合特异性。通过表面等离子体共振技术分析发现,orf239342 特异性结合甘露糖。最后,我们的体外研究表明,甘露糖阻碍了 orf239342 抑制 MCF-7 乳腺癌细胞增殖的能力,为该蛋白结合甘露糖提供了进一步的证据。我们的发现是对 orf239342 特征的突破,即定义其在蘑菇中的功能、与酪氨酸酶的关联,甚至可能在乳腺癌治疗中的应用。此外,这一发现还使得更恰当地将该蛋白命名为双孢蘑菇甘露糖结合蛋白(AbMb)。